Maruo CalciumMaruo Calcium Co., Ltd.4102東証スタンダード化学FY ending Mar 2026, consolidated, J-GAAP
Out of every ¥100 of sales, about ¥1 is left as operating profit. Revenue changed -1.6% from the prior year, operating profit +1393.1%.
Net margin × asset turnover = ROA; ROA × financial leverage = ROE
Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.
| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE |
|---|---|---|---|---|---|
| 2022 | 1.6% | 0.74× | 1.2% | 2.26× | 2.8% |
| 2023 | 0.9% | 0.77× | 0.7% | 2.35× | 1.7% |
| 2024 | 1.9% | 0.76× | 1.5% | 2.41× | 3.5% |
| 2025 | 1.2% | 0.76× | 0.9% | 2.37× | 2.1% |
| 2026 | 2.3% | 0.74× | 1.7% | 2.34× | 4.0% |
Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.
Annual trends in tangible-asset ratios and goodwill balance.
Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition
Track R&D investment and how long operating capital remains tied up before sales turn into cash.
R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 11,567 | 12,594 | 12,889 | 12,843 | 12,639 |
| Cost of revenue | 9,422 | 10,287 | 10,613 | 10,681 | 10,444 |
| Gross profit | 2,146 | 2,307 | 2,276 | 2,162 | 2,195 |
| SG&A | 2,007 | 2,273 | 2,138 | 2,156 | 2,109 |
| Operating income | 138 | 34 | 137 | 6 | 85 |
| Pretax income | 279 | 166 | 325 | 262 | 382 |
| Income tax | 79 | 55 | 108 | 92 | 84 |
| Net income attributable to owners | 191 | 117 | 249 | 149 | 294 |
| Operating margin | 1.2% | 0.3% | 1.1% | 0.0% | 0.7% |
Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.
Each bar totals 100% of assets; other is the residual.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Cash and equivalents | ¥2.68B | ¥3.02B | ¥2.46B | ¥1.67B | ¥1.91B |
| Total assets | ¥15.6B | ¥17B | ¥17B | ¥16.9B | ¥17.1B |
| Net assets | ¥9.3B | ¥9.7B | ¥9.99B | ¥10.2B | ¥10.3B |
| Share capital | ¥876.6M | ¥876.6M | ¥876.6M | ¥876.6M | ¥876.6M |
| Property, plant and equipment | ¥3.07B | ¥3.18B | ¥3.22B | ¥3.37B | ¥3.2B |
| Intangible assets excluding goodwill | ¥45.6M | ¥40.9M | ¥59M | ¥51M | ¥60.5M |
| Investment securities | ¥3.31B | ¥3.72B | ¥3.89B | ¥4.55B | ¥4.72B |
| Current assets | ¥8.83B | ¥9.7B | ¥9.5B | ¥8.56B | ¥8.83B |
| Current liabilities | ¥3.22B | ¥3.7B | ¥4.79B | ¥3.24B | ¥3.34B |
| Trade payables | ¥1.97B | — | — | — | — |
| Short-term borrowings | ¥299.9M | ¥668.7M | ¥909.1M | — | — |
| Long-term borrowings | ¥1.18B | ¥1.49B | ¥623.4M | ¥1.77B | ¥1.82B |
| Bonds | ¥500M | ¥500M | — | — | — |
| Interest-bearing debt | ¥1.98Bderived | ¥2.66Bderived | — | — | — |
| Total liabilities | ¥6.34B | ¥7.29B | ¥7.02B | ¥6.66B | ¥6.84B |
| Non-controlling interests | ¥393.8M | ¥396.6M | ¥372.5M | ¥407.6M | ¥213M |
| Equity attributable to owners of parent | ¥6.92B | ¥6.99B | ¥7.13B | ¥7.16B | ¥7.36B |
| Retained earnings | ¥5.77B | ¥5.82B | ¥6B | ¥6.08B | ¥6.34B |
| Treasury stock | -¥172.8M | -¥148M | -¥189.9M | -¥247.5M | -¥297.2M |
EDINET (FSA Japan)
有価証券報告書－第78期(2025/04/01－2026/03/31)
EDINET (FSA Japan)
有価証券報告書－第77期(2024/04/01－2025/03/31)
EDINET (FSA Japan)
有価証券報告書－第76期(2023/04/01－2024/03/31)
EDINET (FSA Japan)
有価証券報告書－第75期(2022/04/01－2023/03/31)
EDINET (FSA Japan)
訂正有価証券報告書－第74期(令和3年4月1日－令和4年3月31日)
EDINET (FSA Japan)
有価証券報告書－第73期(令和2年4月1日－令和3年3月31日)
Extracted from XBRL: 52 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.